Skip to content

Evaluation of efficacy of Peganum harmala extract on patients with head lice

Evaluation of the efficacy of a formulation of Peganum harmala aqueous extract on patients with head lice

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160306026938N12
Enrollment
25
Registered
2022-10-18
Start date
2022-12-12
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head lice. Pediculosis due to Pediculus humanus capitis

Interventions

Intervention group: recipient of gel formulation containing aqueous extract of Peganum harmala plus carbomer and sodium hydroxide. In three consecutive days, once a day, the patient smears all the inf

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Conformity with head lice diagnostic criteria Age range between 18 and 65 years Signing informed consent Being in healthy condition Not using local or systemic anti-lice products during the recent infection

Exclusion criteria

Exclusion criteria: Local or systemic anti-lice treatment or use of hair dye during or before the study period Having serious diseases or extensive wounds, especially in the scalp area (such as impetigo or eczema), chronic scalp disorders (such as psoriasis, chronic dermatosis) and secondary scalp infection known allergy to any of the components of the product Treatment with antibiotics (cotrimoxazole, trimethoprim, tetracycline) or anthelmintics (such as ivermectin, levamisole, albendazole) in the last 1 month or other local or systemic drugs that may lead to errors in the test

Design outcomes

Primary

MeasureTime frame
Lice levels. Timepoint: Before the initiation of intervention and the day after the last application of formulation. Method of measurement: Scoring the patients' symptoms based on a 0-10 Likert Scale with regard to improvements in symptoms (0=no improvement; 10= complete improvement).

Secondary

MeasureTime frame
Quality of life. Timepoint: Before the start of the intervention and one day after the last use of the formulation. Method of measurement: Completion of a 30-question questionnaire on the quality of life of head lice patients by the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Vazirian

Tehran University of Medical Sciences

Vazirian_m@tums.ac.ir+98 21 6412 1223

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026